Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06744907

Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion

Conditions: Spinal Fusion

Sex: All
Ages: N/A – 26 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 60
Sponsor: Akron Children's Hospital

Location: Akron Children's Hospital Akron Ohio

Summary

Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.

Eligibility Criteria

Inclusion Criteria * Males and females * Undergoing primary posterior spinal fusion of the thoracic and/or lumbar spine * English Speaking Exclusion Criteria * Patients who have undergone prior spinal surgery * Undergoing procedures other than primary posterior spinal fusion of the thoracic and/or lumbar spine (cervical fusion, anterior surgery, growth-friendly instrumentation) * Any contraindication to povidone-iodine, including pregnancy, allergy, or prior treatment with radioiodine

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06744907). StuddyBuddy aggregates publicly available trial information.